glp-1 drugs india Ahead of its time, a drug almost made it out of GLP-1 gold rush under scanner:

Where the research stands and where its heading As the FDA has not approved GLP-1 drugs for addiction treatment, they are still not covered by insurance companies

How often do you ever have to double-check your medication

111 Health economics The economic implications of widespread GLP-1 RA use necessitate thorough evaluation

Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made

Conflict of interest Author AA has received consulting fees from AbbVie, Allergan, Amgen, Arena, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion, Eli-Lilly, Ferring, Galapagos, Gilead, Janssen, MSD, Mylan, Pfizer, Protagonist Therapeutics, Roche, Samsung Bioepis, Sandoz and Takeda

Problems can occur if stomach-emptying slows too much